EvidenceLib · Open textbook · CC BY 4.0
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, David J Bloomfield, Charlie Chan, Suzy Cleator, Charlotte E Coles, Ellen Donovan, Helen Fleming, David Glynn, Andrew Goodman, Susan Griffin, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Zohal Nabi, Jaymini Patel, Elinor Sawyer, Navita Somaiah, Isabel Syndikus, Karen Venables, John R Yarnold, Judith M Bliss · 10 sections in 10 chapters. Each section is its own page.
Introduction
Methods
Radiotherapy quality assurance
Acute toxicity sub-studies
Main Trial
Main Trial cost-effectiveness analysis
Nodal Sub-Study
Discussion
References
Acknowledgements
Attribution. Adrian Murray Brunt; Joanne S Haviland; Duncan A Wheatley; Mark A Sydenham; David J Bloomfield; Charlie Chan et al. (2023). One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT. National Institute for Health and Care Research. Copyright © 2023 Brunt et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK597550. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.